Research reveals how Tau aggregates can contribute to cell death in Alzheimer’s disease

New evidence suggests a mechanism by which progressive accumulation of Tau protein in brain cells may lead to Alzheimer’s disease. Scientists studied more than 600 human brains and fruit fly models of Alzheimer’s disease...

A golden generation

can the precious metal hold the key to killing cancerous cells? In the second century A.D., during the Han dynasty, a Chinese author and alchemist known as Wei Boyang is believed to have written: “Gold...

Hope in the treatment of kidney disease

Research into kidney disease is offering hope for sufferers in the years to come. One piece of research by a Kidney Research UK-funded scientist has made some vital advances in helping to understand a virus...

System could tackle resistant bugs

Once resistant bugs are established in an environment, it can be difficult to eliminate them using ordinary cleaning methods but specialist companies have developed techniques for cleansing an area or individuals.  Rooms and whole departments...

Nominations now open for the 2014 biomedical awards

Bionow is urging companies and individuals across the North of England to nominate their outstanding achievements for the prestigious 2014 Biomedical Awards. The Awards, now in its 2nd year will take place on Thursday 24...

Heart Disease: 
A primary cause of death

Dr Catrin Rutland BSc PGCHE MSc MMedSci PhD SFHEA FAS Heart disease is one of the primary causes of death throughout the world in both humans and animals. Research at The School of Veterinary Medicine...

Better understanding of immunology offers hope for the future

Recent years have seen dramatic strides being taken in the science of immunology – the capacity to direct the body’s natural defences against specific illnesses and conditions. So dramatic have the strides been that scientists’...

Three-parent baby technology clears final hurdle

When science is at its best, it pushes the boundaries of what is possible and makes us think about the big questions. Even if the issues it raises are deeply uncomfortable. That has certainly been...

Concerns expressed on 
drug-resistant infections

Another major concern for those developing new drugs is the risk that illnesses become resistant to them, with significant worries about antibiotics. More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well...

Recruiting the right people for medical research

Clinical research is making massive strides in the way we treat illnesses, extending length and quality of life for the patient. Making the breakthroughs possible are medical researchers who rely heavily on the willingness...

Collaboration key as consortium targets Autism breakthroughs

Everywhere you look in the world of drug discovery, the talk is of collaboration, of sharing knowledge for the wider good. Collaboration is certainly key to the work done by an international consortium of scientists,...

Research at the interface of technology and life sciences

Professor Jens Jordan, Director of the Institute of Aerospace Medicine The Institute of Aerospace Medicine at the German Aerospace Center (DLR) comprises departments in Cologne and in Hamburg with internationally unique research infrastructure. At DLR, the...

Cell therapy manufacturing –making the future now

There is no mistaking the sure but steady revolution happening in cell therapy.  With the long-held promise now rewarded with greater funding, investment and belief, the change in gear has been dizzying. However, this is...

Impact of latest innovative gastroenterology research for patient benefit

According to the British Society of Gastroenterology, the burden of gastrointestinal and liver disease is heavy for patients, the NHS, and the economy. Gastrointestinal disease is the third most common cause of death, and...

Looking for a partner for your biosimilar clinical trial?

BioKinetic Europe is one of the UK’s leading early phase clinical research organizations with experience in over 400 clinical trials.  Our Phase I portfolio comprises BE/BA studies, SAD/MAD/Proof of Concept, TQTc, DDI, vaccine and...

Improving the way information is shared

Effective sharing of information is at the heart of work to develop the world’s largest database for cancer drug discovery, which has been revolutionised by adding 3D structures of faulty proteins and maps of...